Patient Square Capital LP Diversified Active

Location: Menlo Park, CA

CIK: 0001819257 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $267M (100.0% shares, 0.0% debt)

Holdings (20)

ROIV ROIVANT SCIENCES LTD 55.2%

Value $148M Shares 12,480,000 Est. Cost $7.21 Unrealized +63.9%

LQDA LIQUIDIA CORPORATION 8.2%

Value $21.88M Shares 1,860,371 Est. Cost $13.90 Unrealized -21.4%

INSM INSMED INC 7.9%

Value $21.21M Shares 307,167 Est. Cost $73.01 Unrealized -1.4%

CGEM CULLINAN THERAPEUTICS INC 4.0%

Value $10.7M Shares 878,897 Est. Cost $17.53 Unrealized -18.0%

EYPT EYEPOINT PHARMACEUTICALS 3.9%

Value $10.51M Shares 1,410,331 Est. Cost $8.80 Unrealized +5.8%

NRIX NURIX THERAPEUTICS, INC. 3.1%

Value $8.408M Shares 446,296 Est. Cost $22.73 Unrealized +0.9%

— INTRA-CELLULAR THERAPIES INC. 2.2%

Value $6.013M Shares 71,990 Est. Cost $83.52 Unrealized —

ELVN ENLIVEN THERAPEUTICS INC 1.9%

Value $5.041M Shares 224,038 Est. Cost $24.81 Unrealized +4.5%

GERN GERON CORPORATION 1.7%

Value $4.677M Shares 1,321,268 Est. Cost $3.99 Unrealized 0.0%

OCUL OCULAR THERAPEUTIX, INC. 1.5%

Value $4.022M Shares 470,919 Est. Cost $9.00 Unrealized +8.4%

AGIO AGIOS PHARMACEUTICALS, INC. 1.5%

Value $4M Shares 121,732 Est. Cost $46.98 Unrealized 0.0%

PHVS PHARVARIS N V 1.5%

Value $3.98M Shares 207,603 Est. Cost $18.27 Unrealized +12.7%

IRON DISC MEDICINE, INC. 1.3%

Value $3.576M Shares 56,400 Est. Cost $57.84 Unrealized 0.0%

— SPRINGWORKS THERAPEUTICS, INC. 1.3%

Value $3.365M Shares 93,137 Est. Cost $36.13 Unrealized —

ALLO ALLOGENE THERAPEUTICS, INC. 1.2%

Value $3.174M Shares 1,489,909 Est. Cost $2.47 Unrealized 0.0%

MIRM MIRUM PHARMACEUTICALS, INC. 1.0%

Value $2.684M Shares 64,900 Est. Cost $41.67 Unrealized 0.0%

NTLA INTELLIA THERAPEUTICS, INC. 0.9%

Value $2.518M Shares 215,981 Est. Cost $20.04 Unrealized -22.1%

ARVN ARVINAS, INC. 0.6%

Value $1.661M Shares 86,627 Est. Cost $24.30 Unrealized 0.0%

SRRK SCHOLAR ROCK HOLDING CORPORATION 0.5%

Value $1.383M Shares 32,000 Est. Cost $32.56 Unrealized 0.0%

— ASTRIA THERAPEUTICS INC 0.4%

Value $939K Shares 105,057 Est. Cost $9.72 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ROIV	ROIVANT SCIENCES LTD	12,480,000	$148M	55.2%	$7.21	+63.9%	SHS	G76279101
LQDA	LIQUIDIA CORPORATION	1,860,371	$21.88M	8.2%	$13.90	-21.4%	COM NEW	53635D202
INSM	INSMED INC	307,167	$21.21M	7.9%	$73.01	-1.4%	COM PAR $.01	457669307
CGEM	CULLINAN THERAPEUTICS INC	878,897	$10.7M	4.0%	$17.53	-18.0%	COM	230031106
EYPT	EYEPOINT PHARMACEUTICALS	1,410,331	$10.51M	3.9%	$8.80	+5.8%	COM NEW	30233G209
NRIX	NURIX THERAPEUTICS, INC.	446,296	$8.408M	3.1%	$22.73	+0.9%	COM	67080M103
—	INTRA-CELLULAR THERAPIES INC.	71,990	$6.013M	2.2%	$83.52	—	COM	46116X101
ELVN	ENLIVEN THERAPEUTICS INC	224,038	$5.041M	1.9%	$24.81	+4.5%	COM	29337E102
GERN	GERON CORPORATION	1,321,268	$4.677M	1.7%	$3.99	0.0%	COM	374163103
OCUL	OCULAR THERAPEUTIX, INC.	470,919	$4.022M	1.5%	$9.00	+8.4%	COM	67576A100
AGIO	AGIOS PHARMACEUTICALS, INC.	121,732	$4M	1.5%	$46.98	0.0%	COM	00847X104
PHVS	PHARVARIS N V	207,603	$3.98M	1.5%	$18.27	+12.7%	COM	N69605108
IRON	DISC MEDICINE, INC.	56,400	$3.576M	1.3%	$57.84	0.0%	COM	254604101
—	SPRINGWORKS THERAPEUTICS, INC.	93,137	$3.365M	1.3%	$36.13	—	COM	85205L107
ALLO	ALLOGENE THERAPEUTICS, INC.	1,489,909	$3.174M	1.2%	$2.47	0.0%	COM	019770106
MIRM	MIRUM PHARMACEUTICALS, INC.	64,900	$2.684M	1.0%	$41.67	0.0%	COM	604749101
NTLA	INTELLIA THERAPEUTICS, INC.	215,981	$2.518M	0.9%	$20.04	-22.1%	COM	45826J105
ARVN	ARVINAS, INC.	86,627	$1.661M	0.6%	$24.30	0.0%	COM	04335A105
SRRK	SCHOLAR ROCK HOLDING CORPORATION	32,000	$1.383M	0.5%	$32.56	0.0%	COM	80706P103
—	ASTRIA THERAPEUTICS INC	105,057	$939K	0.4%	$9.72	—	COM	04635X102